Acadia Healthcare (NASDAQ:ACHC) Upgraded by Wall Street Zen to Hold Rating

Key Points

• Acadia Healthcare's rating was upgraded from "sell" to "hold" by Wall Street Zen, with five analysts currently rating the stock as hold and six as buy.
• The stock opened at $21.09, with a market capitalization of $1.94 billion, and has experienced a 12-month range of $20.35 to $82.40.
• In its recent quarterly earnings report, Acadia Healthcare reported earnings of $0.40 per share, surpassing the consensus estimate of $0.35, with revenue of $770.51 million, marking a year-over-year increase of 0.3%.

Wall Street Zen upgraded shares of Acadia Healthcare (NASDAQ:ACHC - Free Report) from a sell rating to a hold rating in a research note issued to investors on Sunday morning.

Several other equities research analysts also recently commented on ACHC. Barclays cut their target price on shares of Acadia Healthcare from $35.00 to $28.00 and set an "equal weight" rating on the stock in a report on Wednesday, May 14th. Guggenheim assumed coverage on Acadia Healthcare in a research note on Wednesday, April 9th. They issued a "buy" rating and a $36.00 target price for the company. Mizuho dropped their price target on Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating on the stock in a research report on Wednesday, May 14th. KeyCorp lowered their target price on Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating for the company in a research note on Wednesday, May 14th. Finally, Stephens raised shares of Acadia Healthcare to a "hold" rating in a research note on Monday, June 2nd. Five equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company's stock. Based on data from MarketBeat.com, Acadia Healthcare currently has an average rating of "Moderate Buy" and a consensus target price of $47.94.

Acadia Healthcare Trading Up 2.0%

Shares of ACHC traded up $0.42 on Friday, reaching $21.79. 2,657,548 shares of the company's stock were exchanged, compared to its average volume of 2,141,846. Acadia Healthcare has a 12 month low of $20.35 and a 12 month high of $82.40. The stock has a market capitalization of $2.01 billion, a P/E ratio of 10.73, a price-to-earnings-growth ratio of 4.02 and a beta of 0.88. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.72. The business has a 50 day moving average price of $22.47 and a two-hundred day moving average price of $28.34.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last posted its quarterly earnings results on Monday, May 12th. The company reported $0.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.35 by $0.05. Acadia Healthcare had a return on equity of 8.72% and a net margin of 5.94%. The business had revenue of $770.51 million for the quarter, compared to analyst estimates of $769.90 million. During the same period last year, the company earned $0.84 EPS. The firm's revenue was up .3% on a year-over-year basis. Research analysts anticipate that Acadia Healthcare will post 3.38 earnings per share for the current year.

Institutional Investors Weigh In On Acadia Healthcare

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Caitong International Asset Management Co. Ltd raised its position in shares of Acadia Healthcare by 11,218.2% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 1,245 shares of the company's stock valued at $38,000 after buying an additional 1,234 shares in the last quarter. Quadrant Capital Group LLC lifted its stake in Acadia Healthcare by 287.1% in the 4th quarter. Quadrant Capital Group LLC now owns 1,258 shares of the company's stock valued at $50,000 after purchasing an additional 933 shares during the last quarter. UMB Bank n.a. grew its position in Acadia Healthcare by 149.5% during the 1st quarter. UMB Bank n.a. now owns 1,260 shares of the company's stock worth $38,000 after acquiring an additional 755 shares during the last quarter. State of Wyoming acquired a new position in Acadia Healthcare in the 4th quarter valued at approximately $56,000. Finally, Covestor Ltd increased its stake in shares of Acadia Healthcare by 27.2% in the fourth quarter. Covestor Ltd now owns 1,450 shares of the company's stock valued at $58,000 after buying an additional 310 shares during the period.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.